VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma

American Journal of Pathology

Volumn 182, Issue 4, 2013, Pages 1379-1390

  Foxton, Richard H ^a   Finkelstein, Arthur ^a   Vijay, Sauparnika ^a   Dahlmann Noor, Annegret ^a   Khaw, Peng T ^a   Morgan, James E ^b   Shima, David T ^a   Ng, Yin Shan ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAUROSPORINE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL ISOLATION; CELL SURVIVAL; EYE PROTECTION; GLAUCOMA; INTRAOCULAR HYPERTENSION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINA GANGLION CELL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASES; CELL DEATH; CELLS, CULTURED; CYTOPROTECTION; DISEASE MODELS, ANIMAL; GLAUCOMA; NEUROPILINS; NEUROPROTECTIVE AGENTS; NEUTRALIZATION TESTS; OCULAR HYPERTENSION; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION; TOXICITY TESTS, ACUTE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84875185167     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.12.032     Document Type: Article

References (55)

1. I. Kim, A.M. Ryan, R. Rohan, S. Amano, S. Agular, J.W. Miller, and A.P. Adamis Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes Invest Ophthalmol Vis Sci 40 1999 2115 2121
2. S. Soker, S. Takashima, H.Q. Miao, G. Neufeld, and M. Klagsbrun Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor Cell 92 1998 735 745
3. K.L. Jin, X.O. Mao, and D.A. Greenberg Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia Proc Natl Acad Sci U S A 97 2000 10242 10247
4. E. Gomes, L. Papa, T. Hao, and P. Rockwell The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells Mol Cell Biochem 305 2007 179 190
5. L. Tolosa, M. Mir, V.J. Asensio, G. Olmos, and J. Llado Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase J Neurochem 105 2008 1080 1090
6. M. Sondell, G. Lundborg, and M. Kanje Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system J Neurosci 19 1999 5731 5740
7. L. Erskine, S. Reijntjes, T. Pratt, L. Denti, Q. Schwarz, J.M. Vieira, B. Alakakone, D. Shewan, and C. Ruhrberg VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm Neuron 70 2011 951 965
8. U. Kilic, E. Kilic, A. Jarve, Z. Guo, A. Spudich, K. Bieber, U. Barzena, C.L. Bassetti, H.H. Marti, and D.M. Hermann Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways J Neurosci 26 2006 12439 12446
9. K. Nishijima, Y.S. Ng, L. Zhong, J. Bradley, W. Schubert, N. Jo, J. Akita, S.J. Samuelsson, G.S. Robinson, A.P. Adamis, and D.T. Shima Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury Am J Pathol 171 2007 53 67
10. M. Azzouz, G.S. Ralph, E. Storkebaum, L.E. Walmsley, K.A. Mitrophanous, S.M. Kingsman, P. Carmeliet, and N.D. Mazarakis VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model Nature 429 2004 413 417
11. Y. Sun, K. Jin, L. Xie, J. Childs, X.O. Mao, A. Logvinova, and D.A. Greenberg VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia J Clin Invest 111 2003 1843 1851
12. A. Cariboni, K. Davidson, E. Dozio, F. Memi, Q. Schwarz, F. Stossi, J.G. Parnavelas, and C. Ruhrberg VEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vessels Development 138 2011 3723 3733
13. A. Brockington, P.R. Heath, H. Holden, P. Kasher, F.L. Bender, F. Claes, D. Lambrechts, M. Sendtner, P. Carmeliet, and P.J. Shaw Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosis BMC Genomics 11 2010 203
14. V. Chong Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors Ophthalmologica 227 Suppl 1 2012 2 10
15. N. Ferrara, K.J. Hillan, and W. Novotny Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy Biochem Biophys Res Commun 333 2005 328 335
16. M.B. Horsley, and M.Y. Kahook Anti-VEGF therapy for glaucoma Curr Opin Ophthalmol 21 2010 112 117
17. R.M. Sappington, M. Chan, and D.J. Calkins Interleukin-6 protects retinal ganglion cells from pressure-induced death Invest Ophthalmol Vis Sci 47 2006 2932 2942
18. X. Wang, M.L. Archibald, K. Stevens, W.H. Baldridge, and B.C. Chauhan Cyan fluorescent protein (CFP) expressing cells in the retina of Thy1-CFP transgenic mice before and after optic nerve injury Neurosci Lett 468 2010 110 114
19. G. Tezel, and X. Yang Caspase-independent component of retinal ganglion cell death, in vitro Invest Ophthalmol Vis Sci 45 2004 4049 4059
20. P.A. Samsel, L. Kisiswa, J.T. Erichsen, S.D. Cross, and J.E. Morgan A novel method for the induction of experimental glaucoma using magnetic microspheres Invest Ophthalmol Vis Sci 52 2011 1671 1675
21. M. Almasieh, A.M. Wilson, B. Morquette, J.L. Cueva Vargas, and A. Di Polo The molecular basis of retinal ganglion cell death in glaucoma Prog Retin Eye Res 31 2012 152 181
22. H. Matsuzaki, M. Tamatani, A. Yamaguchi, K. Namikawa, H. Kiyama, M.P. Vitek, N. Mitsuda, and M. Tohyama Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades FASEB J 15 2001 1218 1220
23. L. Guo, T.E. Salt, A. Maass, V. Luong, S.E. Moss, F.W. Fitzke, and M.F. Cordeiro Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo Invest Ophthalmol Vis Sci 47 2006 626 633
24. K. Kortuem, L.K. Geiger, and L.A. Levin Differential susceptibility of retinal ganglion cells to reactive oxygen species Invest Ophthalmol Vis Sci 41 2000 3176 3182
25. X. Wang, A. Zaidi, R. Pal, A.S. Garrett, R. Braceras, X.W. Chen, M.L. Michaelis, and E.K. Michaelis Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress BMC Neurosci 10 2009 12
26. C. Fuchs, V. Forster, E. Balse, J.A. Sahel, S. Picaud, and L.H. Tessier Retinal-cell-conditioned medium prevents TNF-alpha-induced apoptosis of purified ganglion cells Invest Ophthalmol Vis Sci 46 2005 2983 2991
27. Y. Kitaoka, Y. Munemasa, T. Nakazawa, and S. Ueno NMDA-induced interleukin-1beta expression is mediated by nuclear factor-kappa B p65 in the retina Brain Res 1142 2007 247 255
28. H.S. Kim, and C.K. Park Retinal ganglion cell death is delayed by activation of retinal intrinsic cell survival program Brain Res 1057 2005 17 28
29. E.M. Ullian, W.B. Barkis, S. Chen, J.S. Diamond, and B.A. Barres Invulnerability of retinal ganglion cells to NMDA excitotoxicity Mol Cell Neurosci 26 2004 544 557
30. A. Caballero-Benitez, and J. Moran Caspase activation pathways induced by staurosporine and low potassium: role of caspase-2 J Neurosci Res 71 2003 383 396
31. F. Mackenzie, and C. Ruhrberg Diverse roles for VEGF-A in the nervous system Development 139 2012 1371 1380
32. L.M. Wise, N. Ueda, N.H. Dryden, S.B. Fleming, C. Caesar, S. Roufail, M.G. Achen, S.A. Stacker, and A.A. Mercer Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens J Biol Chem 278 2003 38004 38014
33. D. Chauvier, S. Ankri, C. Charriaut-Marlangue, R. Casimir, and E. Jacotot Broad-spectrum caspase inhibitors: from myth to reality? Cell Death Differ 14 2007 387 391
34. A. Sommer, J.M. Tielsch, J. Katz, H.A. Quigley, J.D. Gottsch, J. Javitt, and K. Singh Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey Arch Ophthalmol 109 1991 1090 1095
35. M.B. Wax, G. Tezel, and P.D. Edward Clinical and ocular histopathological findings in a patient with normal-pressure glaucoma Arch Ophthalmol 116 1998 993 1001
36. L.A. Kerrigan, D.J. Zack, H.A. Quigley, S.D. Smith, and M.E. Pease TUNEL-positive ganglion cells in human primary open-angle glaucoma Arch Ophthalmol 115 1997 1031 1035
37. E. Garcia-Valenzuela, S. Shareef, J. Walsh, and S.C. Sharma Programmed cell death of retinal ganglion cells during experimental glaucoma Exp Eye Res 61 1995 33 44
38. R.T. Libby, Y. Li, O.V. Savinova, J. Barter, R.S. Smith, R.W. Nickells, and S.W. John Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage PLoS Genet 1 2005 17 26
39. V.A. Hanninen, M.B. Pantcheva, E.E. Freeman, N.R. Poulin, and C.L. Grosskreutz Activation of caspase 9 in a rat model of experimental glaucoma Curr Eye Res 25 2002 389 395
40. T.C. Jakobs, R.T. Libby, Y. Ben, S.W. John, and R.H. Masland Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice J Cell Biol 171 2005 313 325
41. H.P. Gerber, A. McMurtrey, J. Kowalski, M. Yan, B.A. Keyt, V. Dixit, and N. Ferrara Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: requirement for Flk-1/KDR activation J Biol Chem 273 1998 30336 30343
42. M. Saint-Geniez, A.S. Maharaj, T.E. Walshe, B.A. Tucker, E. Sekiyama, T. Kurihara, D.C. Darland, M.J. Young, and P.A. D'Amore Endogenous VEGF is required for visual function: evidence for a survival role on Müller cells and photoreceptors PLoS One 3 2008 e3554
43. P.A. D'Amore Vascular endothelial cell growth factor-A: not just for endothelial cells anymore Am J Pathol 171 2007 14 18
44. K. Jin, X.O. Mao, S.P. Batteur, E. McEachron, A. Leahy, and D.A. Greenberg Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor Neuroscience 108 2001 351 358
45. W. Cui, W. Li, Y. Zhao, S. Mak, Y. Gao, J. Luo, H. Zhang, Y. Liu, P.R. Carlier, J. Rong, and Y. Han Preventing HO-induced apoptosis in cerebellar granule neurons by regulating the VEGFR-2/Akt signaling pathway using a novel dimeric antiacetylcholinesterase bis(12)-hupyridone Brain Res 1394 2011 14 23
46. P. Carmeliet, and M. Tessier-Lavigne Common mechanisms of nerve and blood vessel wiring Nature 436 2005 193 200
47. Y. Ma, W. Liu, Y. Wang, X. Chao, Y. Qu, K. Wang, and Z. Fei VEGF protects rat cortical neurons from mechanical trauma injury induced apoptosis via the MEK/ERK pathway Brain Res Bull 86 2011 441 446
48. K. Ito, G. Caramori, and I.M. Adcock Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease J Pharmacol Exp Ther 321 2007 1 8
49. E. Wittström, H. Holmberg, C. Hvarfner, and S. Andréasson Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab Eur J Ophthalmol 22 2012 563 574
50. J.M. Martinez-de-la-Casa, A. Ruiz-Calvo, F. Saenz-Frances, J. Reche-Frutos, C. Calvo-Gonzalez, J. Donate-Lopez, and J. Garcia-Feijoo Retinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumab Invest Ophthalmol Vis Sci 53 2012 6214 6218
51. L.A. Kerrigan-Baumrind, H.A. Quigley, M.E. Pease, D.F. Kerrigan, and R.S. Mitchell Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons Invest Ophthalmol Vis Sci 41 2000 741 748
52. R. Adler, C. Curcio, D. Hicks, D. Price, and F. Wong Cell death in age-related macular degeneration Mol Vis 5 1999 31
53. G.R. Jackson, and A.J. Barber Visual dysfunction associated with diabetic retinopathy Curr Diab Rep 10 2010 380 384
54. A.F. Wright, S.G. Jacobson, A.V. Cideciyan, A.J. Roman, X. Shu, D. Vlachantoni, R.R. McInnes, and R.A. Riemersma Lifespan and mitochondrial control of neurodegeneration Nat Genet 36 2004 1153 1158
55. R.B. Bhisitkul, S. Rofagha, D.S. Boyer, S. Sadda, and K. Zhang Year 7 outcomes for ranibizumab-treated subjects in anchor/marina: a multicenter, prospective cohort study ARVO Meeting Abstracts 53 2012 3679